UpNext: Life Sciences Participants

Tanvir Mahmud '93
Founder and Principal, Find Your Solution

Tanvir Mahmud has more than 20 years’ experience in product development, quality and project management in the life sciences industry including Biogen Idec, Vertex Pharmaceuticals, Boston Scientific, and Consulting Companies. She has a master’s degree in Physical and Biochemistry from University of New Mexico, 1996 and Bachelor of Arts in Chemistry from Middlebury College, 1993 and a master certification in coaching 2009.

Her professional experience relates to research and development, analytical development, formulation development, quality management, chemistry manufacturing and control, drug/device/biologics/combination product stability, training and program management.

Tanvir is a consultant and a trainer at QPS and a Founder and Principal at Find Your Solution (FYS) Consulting and Training, a company offering training and consulting in Risk Management and Continuous Quality improvement for the life sciences industry professionals.

FYS assists companies to achieve results by collecting client’s training requirements, custom designing, developing, and delivering training for employee to improve patient outcomes.

Tanvir designs, develops, and delivers training in Risk Management, cGMP and other customized training for Pharma, Biopharma and Medical Device Industries.


Andre Spring '88
Executive Director, Strategic Market Access at Novartis Oncology.

Andre graduated from Middlebury in 1988 with a French/Spanish joint major. 

She has worked in the BioPharma industry since 1992 in commercial roles including sales and sales management, sales training and operations, and marketing roles including professional, consumer and payer marketing/market access.  During her career in the industry she has worked for Bristol-Myers Squibb, GSK, Merck and currently for Novartis.  She’s worked on brands in Oncology/Hematology, HIV, Hepatitis B and C, rare diseases, diabetes and cardiovascular medicines. 

Andre came to Middlebury after growing up in New Orleans, LA and has worked/relocated in Los Angeles, South Carolina, Louisiana/Mississippi and the NJ/PA areas. 


Brad Schenkel '97
Director, WWHEOR (Bristol-Myers Squibb)

Brad Schenkel, MSc, is a Director in the Bristol-Myers Squibb (BMS), Worldwide Health Economics and Outcomes Research (WWHEOR) Team. Within this team, Brad leads WWHEOR projects and strategy for nivolumab as well as numerous early and new therapeutic assets within the BMS oncology portfolio. Prior to joining BMS, Brad worked for Johnson & Johnson as a Director of their Worldwide Market Access team responsible for health economics and outcomes research in oncology, hematology, dermatology, and immunology, including health economics research projects, meta-analyses, patient reported outcomes studies, and prospective observational and retrospective studies across global markets. Brad has 18 years of experience working in the pharmaceutical industry.

Prior to his work in pharmaceuticals, Brad had 3 years of experience as a Clinical Research Associate at Memorial Sloan-Kettering Cancer Center in New York City. Brad completed his MSc degree in both Economic Evaluation and Health Policy at Dartmouth Medical School in 2001. He attained his BA degree from Middlebury College in 1997 with a major in psychology and a concentration in biology. Brad is currently a member of ISPOR and AMCP.


Penny Post '89
Vice President, Protein Sciences, a Sanofi Company

With a strong background in biochemistry and cell biology, Dr. Post first joined Protein Sciences Corporation in April of 2000. She has since then held management positions in the company’s Process Development, Manufacturing, Quality Control, and Quality Assurance departments, according to the Protein Sciences website.
Promoted to Vice President of Regulatory in 2011, Dr. Post served as the liaison between Protein Sciences and the F.D.A. in the final stages of Flubok’s development and approval. Prior to joining Protein Sciences, Dr. Post was an Associate Research Scientist at Yale University.
In addition to her BA in Biology from Middlebury, Dr. Post received a PhD in Biochemistry and Cellular biology from Carnegie Mellon University.

Caroline Brown '15
Senior Consultant, Clearview Healthcare Partners

Caroline is a Senior Consultant at the life sciences consulting firm ClearView Healthcare Partners. She has served a range of clients with products spanning disease areas, though the majority of her engagements focus on strategy within hematology/oncology, rare disease, and commercialization pathways for cell and gene therapies.

Prior to ClearView, Caroline also held consulting positions at IMS Health, specializing in the hematology diagnostic space. She graduated from Middlebury in 2015 with degrees in biochemistry and Italian.


Jeremy Ward
Albert D. Mead Professor of Biology, Middlebury College

Professor Ward attended Cornell University, majoring in cell biology and genetics and earning his Ph.D. at Weill Cornell Graduate School in Medical Sciences in cancer biology.

He conducted my research at Memorial Sloan Kettering Institute studying the molecular cause of acute promyelocytic leukemia.  His post-doctoral work at The Jackson Laboratory focused on the genetic basis for accurate production of gametes during mammalian meiosis and reproduction. 

His current research interests include reproductive genetics in mammals and genetics in general in diverse systems, inclusive STEM education strategies, and the intersection of biotechnology and society.


Jack Terrett '11
Scientist, Genentech

Jack joined Genentech in 2016 as a Scientist in the Discovery Chemistry group. As a medicinal chemist, Jack's responsibilities involve the design and development of small molecule drugs to target various biological pathways.

Prior to joining Genentech, Jack completed my Ph.D. at Princeton University in the group of David MacMillan. His research focused on the development of new catalytic transformations through the strategic access of reactive intermediates, primarily in the area of photoredox–nickel catalysis.

He graduated from Middlebury College with a BA in Chemistry and Physics minor.